Immune restoration has always been the focus point of cancer therapies offered at MCC. A recent article in the New York Times refers to a study which shows that it is usually wrong in medicine to take for granted that when something might be good for you, more is better!
Immune restoration has always been the focus point of cancer therapies. One good example is the aggressive application of heated chemotherapy during an abdominal operation (HIPEC) with the assumption that one could kill the very last cancer cell which might have been left by the surgeon.
Clear benefit has never been shown but for sure a 8% death rate directly due to the complications of HIPEC. Also, not that long ago, in the 1960’s and early 1970’s, women with breast cancer underwent not only routinely radical mastectomy and removal of underlying musculature but also complete resection of all lymph nodes.